Hematologic

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC96-3

DiraChart Clinical Reference
Protected section 3 of 15
← Document menu
Nursing Home · DiraChart

1. Purpose and clinical relevance

DiraChart Clinical Reference

Section NavigationPart 3 of 15PreviousNext

2. What to assess, technique, and required data

Assess the hematologic status in the context of the skilled reason and document the judgment:

  • Relevant counts and their trend (hemoglobin/hematocrit, platelets, white count/absolute neutrophil count) and the symptoms of anemia (fatigue, dyspnea, tachycardia, pallor).
  • For thrombocytopenia: bleeding signs (bruising, petechiae, gum/nose bleeding, hematuria, melena) and bleeding precautions; for neutropenia: infection signs and neutropenic precautions, remembering fever may be the only sign.
  • For a transfusion: the order and consent, the pre-transfusion vitals and identity check, and intra-/post-transfusion monitoring for a reaction.

MDS-supportive data

Transfusion and isolation are coded in MDS Section O0110, relevant medications in Section N, and the hematologic diagnosis in Section I. The record must document the counts/trend, the transfusion and its monitoring, and the precautions so the MDS is supported.

Section NavigationPart 3 of 15PreviousNext